Tetraxim

Tetraxim

Manufacturer:

Sanofi Pasteur

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Per 0.5 mL dose Diphtheria toxoid ≥30 IU, tetanus toxoid ≥40 IU, Bordetella pertussis antigens (toxoid 25 mcg, filamentous haemagglutinin 25 mcg), inactivated poliomyelitis virus type 1 40 D antigen units, type 2 8 D antigen units & type 3 32 D antigen units
Indications/Uses
Immunization against DPT & poliomyelitis.
Dosage/Direction for Use
Primary immunization: 0.5 mL IM for 3 doses w/ an interval of 1-2 mth. Booster: 1 yr after primary immunization & at 5 yr.
Contraindications
Allergy to any component of the vaccine.
Special Precautions
Hypersensitivity to neomycin, streptomycin & polymyxin B (substances used in the production of Tetraxim).
Adverse Reactions
Local reactions eg, pain, erythema, induration. Systemic reactions eg, fever, drowsiness, sleeping & eating disorders.
ATC Classification
J07CA02 - diphtheria-pertussis-poliomyelitis-tetanus ; Belongs to the class of combined bacterial and viral vaccines.
Presentation/Packing
Form
Tetraxim vaccine (inj)
Packing/Price
0.5 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in